Vaccines for tuberculosis

Vaccines for tuberculosis

Detalhes bibliográficos
Autor principal:	McShane, H
Formato:	Journal article
Idioma:	English
Publicado em:	CABI Publishing 2013

Registos relacionados

Vaccine strategies against tuberculosis
Por: H McShane
Publicado em: (2009-03-01)

Insights and challenges in tuberculosis vaccine development
Por: McShane, H
Publicado em: (2019)

Tuberculosis vaccines: beyond bacille Calmette–Guérin
Por: McShane, H
Publicado em: (2011)

Tuberculosis vaccines: Beyond bacilli Calmette-Guérin
Por: McShane, H
Publicado em: (2011)

Tuberculosis vaccines: Progress and challenges
Por: Checkley, A, et al.
Publicado em: (2011)

Improving tuberculosis vaccine trial efficiency: a tough nut to crack
Por: McShane, H
Publicado em: (2023)

Why don’t we have an effective tuberculosis vaccine yet?
Por: Davenne, T, et al.
Publicado em: (2016)

Clinical testing of tuberculosis vaccine candidates
Por: Hatherill, M, et al.
Publicado em: (2016)

The VALIDATE network: accelerating vaccine development for tuberculosis, leishmaniasis, melioidosis and leprosy
Por: Vermaak, S, et al.
Publicado em: (2023)

Replacing, reducing and refining the use of animals in tuberculosis vaccine 1 research
Por: Tanner, R, et al.
Publicado em: (2016)

Tuberculosis vaccines in the era of Covid-19 - what is taking us so long?
Por: Dockrell, HM, et al.
Publicado em: (2022)

Human and Bovine Tuberculosis
Por: McShane, H
Publicado em: (2016)

Vaccination against tuberculosis: how can we better BCG?
Por: Pitt, J, et al.
Publicado em: (2013)

Vaccination against tuberculosis: How can we better BCG?
Por: Pitt, J, et al.
Publicado em: (2013)

Tuberculosis vaccines in the era of Covid-19 – what is taking us so long?
Por: Hazel M. Dockrell, et al.
Publicado em: (2022-05-01)

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges
Por: Stylianou, E, et al.
Publicado em: (2019)

Vaccine strategies against tuberculosis.
Por: Mcshane, H
Publicado em: (2009)

Controlled human infection models: is it really feasible to give people tuberculosis?
Por: McShane, H
Publicado em: (2020)

Developing an improved vaccine against tuberculosis.
Por: Mcshane, H
Publicado em: (2004)

Dual neonate vaccine platform against HIV-1 and M. tuberculosis.
Por: Hopkins, R, et al.
Publicado em: (2011)

Local pulmonary immunological biomarkers in tuberculosis
Por: Morrison, H, et al.
Publicado em: (2021)

Tuberculosis vaccines in clinical trials.
Por: Rowland, R, et al.
Publicado em: (2011)

Tuberculosis vaccines: progress and challenges.
Por: Checkley, A, et al.
Publicado em: (2011)

Tuberculosis vaccines: present and future.
Por: Minassian, A, et al.
Publicado em: (2008)

Challenges in developing a controlled human tuberculosis challenge model
Por: Jackson, S, et al.
Publicado em: (2022)

Tuberculosis vaccine promises sterilizing immunity.
Por: Mcshane, H, et al.
Publicado em: (2011)

Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice
Por: Griffiths, K, et al.
Publicado em: (2013)

Tuberculosis vaccines: current status and future prospects.
Por: Fletcher, H, et al.
Publicado em: (2006)

Local Pulmonary Immunological Biomarkers in Tuberculosis
Por: Hazel Morrison, et al.
Publicado em: (2021-03-01)

Towards new TB vaccines
Por: Brazier, B, et al.
Publicado em: (2020)

Current approaches toward identifying a correlate of immune protection from tuberculosis
Por: Satti, I, et al.
Publicado em: (2018)

Vaccines
Por: Minhinnick, A, et al.
Publicado em: (2014)

WHO preferred product characteristics for new vaccines against tuberculosis
Por: Schrager, L, et al.
Publicado em: (2018)

Dual neonate vaccine platform against HIV-1 and M. tuberculosis.
Por: Richard Hopkins, et al.
Publicado em: (2011-01-01)

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations
Por: Hanekom, W, et al.
Publicado em: (2008)

Translational mini-review series on vaccines: Development and evaluation of improved vaccines against tuberculosis.
Por: Sander, C, et al.
Publicado em: (2007)

A New Vaccine for Tuberculosis: The Challenges of Development and Deployment
Por: Fletcher, H, et al.
Publicado em: (2009)

Controlled human infection models in COVID-19 and tuberculosis: current progress and future challenges
Por: Morrison, H, et al.
Publicado em: (2023)

Development of a BCG challenge model for the testing of vaccine candidates against tuberculosis in cattle
Por: Villarreal-Ramos, B, et al.
Publicado em: (2017)

Antibodies and tuberculosis
Por: Jacobs, A, et al.
Publicado em: (2016)